Laboratory preparedness and response with a focus on arboviruses in Europe

Clinical Microbiology and Infection

Volumn 24, Issue 3, 2018, Pages 221-228

  Reusken, C B ^a   Ieven, M ^b,c   Sigfrid, L ^d   Eckerle, I ^e   Koopmans, M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Diagnostics; Emerging diseases; Laboratory preparedness; Microbiology

Indexed keywords

ARBOVIRUS; CLINICAL LABORATORY; DIAGNOSTIC ACCURACY; ENDEMIC DISEASE; EUROPE; HOSPITAL LABORATORY; HUMAN; LABORATORY DIAGNOSIS; NEXT GENERATION SEQUENCING; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; VIRUS DETECTION; VIRUS TRANSMISSION; CIVIL DEFENSE; ISOLATION AND PURIFICATION; LABORATORY TECHNIQUE; ORGANIZATION AND MANAGEMENT; PROCEDURES; VIRUS INFECTION;

ARBOVIRUS INFECTIONS; ARBOVIRUSES; CIVIL DEFENSE; CLINICAL LABORATORY TECHNIQUES; EUROPE; HUMANS;

EID: 85041590080     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2017.12.010     Document Type: Review

References (139)

1. Wilder-Smith, A., Gubler, D.J., Weaver, S.C., Monath, T.P., Heymann, D.L., Scott, T.W., Epidemic arboviral diseases: priorities for research and public health. Lancet Infect Dis 17 (2017), e101–e106.
2. Cleton, N., Koopmans, M., Reimerink, J., Godeke, G.J., Reusken, C., Come fly with me: review of clinically important arboviruses for global travelers. J Clin Virol 55 (2012), 191–203.
3. Liang, G., Gao, X., Gould, E.A., Factors responsible for the emergence of arboviruses; strategies, challenges and limitations for their control. Emerg Microbe Infect, 4, 2015, e18.
4. Mayer, S.V., Tesh, R.B., Vasilakis, N., The emergence of arthropod-borne viral diseases: a global prospective on dengue, chikungunya and zika fevers. Acta Trop 166 (2017), 155–163.
5. Leparc-Goffart, I., Nougairede, A., Cassadou, S., Prat, C., de Lamballerie, X., Chikungunya in the Americas. Lancet, 383, 2014, 514.
6. WHO, WHO statement on the first meeting of the International Health Regulations (2005) (IHR 2005) emergency committee on zika virus and observed increase in neurological disorders and neonatal malformations. 2016, WHO, Geneva Available at: http://www.who.int/mediacentre/news/statements/2016/1st-emergency-committee-zika/en/.
7. WHO, Fifth meeting of the emergency committee under the International Health Regulations (2005) regarding microcephaly, other neurological disorders and zika virus. 2016, WHO Available at: http://www.who.int/mediacentre/news/statements/2016/zika-fifth-ec/en/.
8. Vilibic-Cavlek, T., Kaic, B., Barbic, L., Pem-Novosel, I., Slavic-Vrzic, V., Lesnikar, V., First evidence of simultaneous occurrence of West Nile virus and usutu virus neuroinvasive disease in humans in Croatia during the 2013 outbreak. Infection 42 (2014), 689–695.
9. Tomasello, D., Schlagenhauf, P., Chikungunya and dengue autochthonous cases in Europe, 2007–2012. Travel Med Infect Dis 11 (2013), 274–284.
10. Schaffner, F., Mathis, A., Dengue and dengue vectors in the who European region: past, present, and scenarios for the future. Lancet Infect Dis 14 (2014), 1271–1280.
11. Estrada-Pena, A., Palomar, A.M., Santibanez, P., Sanchez, N., Habela, M.A., Portillo, A., Crimean-Congo hemorrhagic fever virus in ticks, Southwestern Europe, 2010. Emerg Infect Dis, 2012, 179–180.
12. ECDC, Rapid riskassessment: Crimean–Congo haemorrhagic fever in Spain. 2016 Available at: http://ecdc.europa.eu/en/publications/Publications/crimean-congo-haemorrhagic-fever-spain-risk-assessment.pdf.
13. Rizzoli, A., Jimenez-Clavero, M.A., Barzon, L., Cordioli, P., Figuerola, J., Koraka, P., The challenge of West Nile virus in Europe: knowledge gaps and research priorities. Euro Surveill, 20, 2015.
14. Rezza, G., Nicoletti, L., Angelini, R., Romi, R., Finarelli, A.C., Panning, M., et al. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 370 (2007), 1840–1846.
15. Gould, E.A., Gallian, P., De Lamballerie, X., Charrel, R.N., First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality!. Clin Microbiol Infect 16 (2010), 1702–1704.
16. ECDC, ECDC rapid risk assessment; clusters of autochthonous chikungunya cases in Italy, 14 September 2017. 2017, ECDC Available at: https://ecdc.europa.eu/sites/portal/files/documents/14-Sep-2017-RRA-Chikungunya-Italy_0.pdf.
17. ECDC, Rapid risk assessment: cluster of autochthonous chikungunya cases in France 23 August 2017. 2017, ECDC Available at: https://ecdc.europa.eu/sites/portal/files/documents/RRA-Chikungunya-France-revised-Aug-2017.pdf.
18. Rijks, J.M., Kik, M.L., Slaterus, R., Foppen, R., Stroo, A., IJzer, J., et al. Widespread usutu virus outbreak in birds in The Netherlands, 2016. Euro Surveill, 21, 2016.
19. Garigliany, M., Linden, A., Gilliau, G., Levy, E., Sarlet, M., Franssen, M., et al. Usutu virus, Belgium, 2016. Infect Genet Evol 48 (2016), 116–119.
20. Cadar, D., Luhken, R., van der Jeugd, H., Garigliany, M., Ziegler, U., Keller, M., et al. Widespread activity of multiple lineages of usutu virus, Western Europe, 2016. Euro Surveill, 22, 2017.
21. Grottola, A., Marcacci, M., Tagliazucchi, S., Gennari, W., Di Gennaro, A., Orsini, M., et al. Usutu virus infections in humans: a retrospective analysis in the municipality of Modena, Italy. Clin Microbiol Infect 23 (2017), 33–37.
22. Allering, L., Jost, H., Emmerich, P., Gunther, S., Lattwein, E., Schmidt, M., et al. Detection of usutu virus infection in a healthy blood donor from south-west Germany, 2012. Euro Surveill, 17, 2012.
23. Bakonyi, T., Jungbauer, C., Aberle, S.W., Kolodziejek, J., Dimmel, K., Stiasny, K., et al. Usutu virus infections among blood donors, Austria, July and August 2017 – raising awareness for diagnostic challenges. Euro Surveill, 22, 2017.
24. ECDC, Exotic vectors: mosquito maps. 2016, ECDC Available at: http://ecdc.europa.eu/en/healthtopics/vectors/vector-maps/Pages/VBORNET_maps.aspx.
25. WHO, Zika virus, technical report., 2016, WHO Europe Available at: http://www.euro.who.int/__data/assets/pdf_file/0003/309981/Zika-Virus-Technical-report.pdf.
26. Jupille, H., Seixas, G., Mousson, L., Sousa, C.A., Failloux, A.B., Zika virus, a new threat for europe?. PLoS Negl Trop Dis, 10, 2016, e0004901.
27. Di Luca, M., Severini, F., Toma, L., Boccolini, D., Romi, R., Remoli, M.E., et al. Experimental studies of susceptibility of Italian Aedes albopictus to zika virus. Euro Surveill, 21, 2016.
28. Chouin-Carneiro, T., Vega-Rua, A., Vazeille, M., Yebakima, A., Girod, R., Goindin, D., et al. Differential susceptibilities of Aedes aegypti and Aedes albopictus from the Americas to zika virus. PLoS Negl Trop Dis, 10, 2016, e0004543.
29. Hayes, E.B., Zika virus outside Africa. Emerg Infect Dis 15 (2009), 1347–1350.
30. Weger-Lucarelli, J., Ruckert, C., Chotiwan, N., Nguyen, C., Garcia Luna, S.M., Fauver, J.R., et al. Vector competence of American mosquitoes for three strains of zika virus. PLoS Negl Trop Dis, 10, 2016, e0005101.
31. Guerbois, M., Fernandez-Salas, I., Azar, S.R., Danis-Lozano, R., Alpuche-Aranda, C.M., Leal, G., et al. Outbreak of zika virus infection, Chiapas state, Mexico, 2015, and first confirmed transmission by Aedes aegypti mosquitoes in the Americas. J Infect Dis 214 (2016), 1349–1356.
32. Engler, O., Savini, G., Papa, A., Figuerola, J., Groschup, M.H., Kampen, H., et al. European surveillance for West Nile virus in mosquito populations. Int J Environ Res Public Health 10 (2013), 4869–4895.
33. Platonov, A., Rossi, G., Karan, L., Mironov, K., Busani, L., Rezza, G., Does the Japanese encephalitis virus (JEV) represent a threat for human health in Europe? Detection of JEV RNA sequences in birds collected in Italy. Euro Surveill, 17, 2012.
34. Huber, K., Jansen, S., Leggewie, M., Badusche, M., Schmidt-Chanasit, J., Becker, N., et al. Aedes japonicus japonicus (Diptera: Culicidae) from Germany have vector competence for Japan encephalitis virus but are refractory to infection with West Nile virus. Parasitol Res 113 (2014), 3195–3199.
35. Bakonyi, T., Ferenczi, E., Erdelyi, K., Kutasi, O., Csorgo, T., Seidel, B., et al. Explosive spread of a neuroinvasive lineage 2 West Nile virus in central Europe, 2008/2009. Vet Microbiol 165 (2013), 61–70.
36. Nikolay, B., A review of West Nile and Usutu virus co-circulation in Europe: how much do transmission cycles overlap?. Trans R Soc Trop Med Hyg 109 (2015), 609–618.
37. Faria, N.R., Azevedo Rdo, S., Kraemer, M.U., Souza, R., Cunha, M.S., Hill, S.C., et al. Zika virus in the Americas: early epidemiological and genetic findings. Science 352 (2016), 345–349.
38. Cassadou, S., Boucau, S., Petit-Sinturel, M., Huc, P., Leparc-Goffart, I., Ledrans, M., Emergence of chikungunya fever on the French side of Saint Martin Island, October to December 2013. Euro Surveill, 19, 2014.
39. EuroStat, Tourism statistics—top destinations. EC. 2015 Available at: http://ec.europa.eu/eurostat/statistics-explained/index.php/Tourism_statistics_-_top_destinations.
40. ECDC, Rapid risk assessment: yellow fever among travelers returing from South America. 2017, ECDC Available at: http://ecdc.europa.eu/en/publications/Publications/14-03-2017-RRA-Yellow%20fever,%20Flaviviridae-Suriname,%20Southern%20America.pdf.
41. ECDC, Rapid risk assessment: Zika virus disease epidemic; tenth update, 4 April 2017. 2017, ECDC Available at: http://ecdc.europa.eu/en/publications/Publications/21-03-2017-RRA%20UPDATE%209-Zika%20virus-Americas,%20Caribbean,%20Oceania,%20Asia.pdf.
42. ECDC, Zika virus and safety of substances of human origin; a guide for preparedness activities in Europe; first update, august 2017. 2017, ECDC Available at: https://ecdc.europa.eu/sites/portal/files/documents/Zika-virus-safety-of-substances-of-human-origin-update-2017-web.pdf.
43. Chaskopoulou, A., L'Ambert, G., Petric, D., Bellini, R., Zgomba, M., Groen, T.A., et al. Ecology of West Nile virus across four European countries: review of weather profiles, vector population dynamics and vector control response. Parasit Vectors, 9, 2016, 482.
44. Chancey, C., Grinev, A., Volkova, E., Rios, M., The global ecology and epidemiology of West Nile virus. Biomed Res Int, 2015, 2015, 376230.
45. Brown, L., Medlock, J., Murray, V., Impact of drought on vector-borne diseases—how does one manage the risk?. Public Health 128 (2014), 29–37.
46. Hoch, T., Breton, E., Josse, M., Deniz, A., Guven, E., Vatansever, Z., Identifying main drivers and testing control strategies for CCHFV spread. Exp Appl Acarol 68 (2016), 347–359.
47. Estrada-Pena, A., Ayllon, N., de la Fuente, J., Impact of climate trends on tick-borne pathogen transmission. Front Physiol, 3, 2012, 64.
48. Estrada-Pena, A., Jameson, L., Medlock, J., Vatansever, Z., Tishkova, F., Unraveling the ecological complexities of tick-associated Crimean-Congo hemorrhagic fever virus transmission: a gap analysis for the western Palearctic. Vector Borne Zoonotic Dis 12 (2012), 743–752.
49. Randolph, S.E., To what extent has climate change contributed to the recent epidemiology of tick-borne diseases?. Vet Parasitol 167 (2010), 92–94.
50. Adouchief, S., Smura, T., Sane, J., Vapalahti, O., Kurkela, S., Sindbis virus as a human pathogen-epidemiology, clinical picture and pathogenesis. Rev Med Virol 26 (2016), 221–241.
51. Sigfrid, L., Reusken, C., Eckerle, I., Nussenblatt, V., Lipworth, S., Messina, J., et al. Preparing clinicians for (re-)emerging arbovirus infectious diseases in Europe. Clin Microbiol Infect 24 (2018), 229–239.
52. Gould, E., Pettersson, J., Higgs, S., Charrel, R., de Lamballerie, X., Emerging arboviruses: why today?. One Health 4 (2017), 1–13.
53. Kilpatrick, A.M., Randolph, S.E., Drivers, dynamics, and control of emerging vector-borne zoonotic diseases. Lancet 380 (2012), 1946–1955.
54. Simon-Loriere, E., Faye, O., Prot, M., Casademont, I., Fall, G., Fernandez-Garcia, M.D., et al. Autochthonous Japanese encephalitis with yellow fever coinfection in Africa. N Engl J Med 376 (2017), 1483–1485.
55. de Sousa, R., Reusken, C., Koopmans, M., MERS coronavirus: data gaps for laboratory preparedness. J Clin Virol 59 (2014), 4–11.
56. Reusken, C., Niedrig, M., Pas, S., Anda, P., Baize, S., Charrel, R., et al. Identification of essential outstanding questions for an adequate European laboratory response to ebola virus Zaire West Africa 2014. J Clin Virol 62 (2015), 124–134.
57. Charrel, R., Leparc Goffart, I., Pas, S., de Lamballerie, X., Koopmans, M., Reusken, C., State of knowledge on zika virus for an adequate laboratory response. 2016, Bull WHO E-pub: 10 Feb 2016.
58. Mögling, R., Zeller, H., Revez, J., Koopmans, M. Zika virus laboratory reference group, Reusken, C.B.E.M., Status, quality and specific needs of zika virus diagnostic capacity and capability in national reference laboratories for arboviruses in 30 EU/EEA countries. Euro Surveill, 22, 2017.
59. de Laval, F., Matheus, S., Labrousse, T., Enfissi, A., Rousset, D., Briolant, S., Kinetics of zika viral load in semen. N Engl J Med 377 (2017), 697–699.
60. Jeong, Y.E., Cha, G.W., Cho, J.E., Lee, E.J., Jee, Y., Lee, W.J., Viral and serological kinetics in zika virus-infected patients in South Korea. Virol J, 14, 2017, 70.
61. Joguet, G., Mansuy, J.M., Matusali, G., Hamdi, S., Walschaerts, M., Pavili, L., et al. Effect of acute zika virus infection on sperm and virus clearance in body fluids: a prospective observational study. Lancet Infect Dis 11 (2017), 1200–1208.
62. Rossini, G., Gaibani, P., Vocale, C., Cagarelli, R., Landini, M.P., Comparison of zika virus (ZIKV) RNA detection in plasma, whole blood and urine—case series of travel-associated ZIKV infection imported to Italy, 2016. J Infect 75 (2017), 242–245.
63. Paz-Bailey, G., Rosenberg, E.S., Doyle, K., Munoz-Jordan, J., Santiago, G.A., Klein, L., et al. Persistence of zika virus in body fluids—preliminary report. N Engl J Med, 2017 epub ahead of print.
64. ECDC, Technical report: core functions of microbiology reference laboratories for communicable diseases., 2010, ECDC Available at: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/1006_TER_Core_functions_of_reference_labs.pdf.
65. ECDC, Disease and laboratory networks. 2017, ECDC Available at: https://ecdc.europa.eu/en/about-us/partnerships-and-networks/disease-and-laboratory-networks.
66. WHO, R&D blueprint; list of priority diseases. 2017, WHO Available at: http://www.who.int/blueprint/priority-diseases/en/.
67. ECDC, ECDC tool for the prioritisation of infectious disease threats. 2017, ECDC Available at: https://ecdc.europa.eu/sites/portal/files/documents/Tool-for-disease-priority-ranking_handbook_0_0.pdf.
68. Havelaar, A.H., van Rosse, F., Bucura, C., Toetenel, M.A., Haagsma, J.A., Kurowicka, D., et al. Prioritizing emerging zoonoses in The Netherlands. PLoS One, 5, 2010, e13965.
69. Taylor, L.H., Latham, S.M., Woolhouse, M.E., Risk factors for human disease emergence. Philos Trans R Soc Lond B Biol Sci 356 (2001), 983–989.
70. Olival, K.J., Willoughby, A.R., Prioritizing the ‘dormant’ flaviviruses. Ecohealth 14 (2017), 1–2.
71. Olival, K.J., Hosseini, P.R., Zambrana-Torrelio, C., Ross, N., Bogich, T.L., Daszak, P., Host and viral traits predict zoonotic spillover from mammals. Nature 546 (2017), 646–650.
72. Palmer, S., Brown, D., Morgan, D., Early qualitative risk assessment of the emerging zoonotic potential of animal diseases. BMJ 331 (2005), 1256–1260.
73. Krause, G., Working Group on Prioritisation at the Robert Koch I. Prioritisation of infectious diseases in public health—call for comments. Euro Surveill, 13, 2008.
74. Tilston-Lunel, N.L., Shi, X., Elliott, R.M., Acrani, G.O., The potential for reassortment between Oropouche and Schmallenberg orthobunyaviruses. Viruses, 9, 2017.
75. Beer, M., Conraths, F.J., van der Poel, W.H., ‘Schmallenberg virus'—a novel orthobunyavirus emerging in Europe. Epidemiol Infect 141 (2013), 1–8.
76. Aguilar, P.V., Barrett, A.D., Saeed, M.F., Watts, D.M., Russell, K., Guevara, C., et al. Iquitos virus: a novel reassortant orthobunyavirus associated with human illness in Peru. PLoS Negl Trop Dis, 5, 2011, e1315.
77. Luis, A.D., Hayman, D.T., O'Shea, T.J., Cryan, P.M., Gilbert, A.T., Pulliam, J.R., et al. A comparison of bats and rodents as reservoirs of zoonotic viruses: are bats special?. Proc Biol Sci, 280, 2013, 20122753.
78. Moratelli, R., Calisher, C.H., Bats and zoonotic viruses: can we confidently link bats with emerging deadly viruses?. Mem Inst Oswaldo Cruz 110 (2015), 1–22.
79. Drew, T.W., Mueller-Doblies, U.U., Dual use issues in research—a subject of increasing concern?. Vaccine 35 (2017), 5990–5994.
80. CBD, The Nagoya protocol on access and benefit-sharing. 2014, CBD Available at: https://www.cbd.int/abs/.
81. Aarestrup, F.M., Koopmans, M.G., Sharing data for global infectious disease surveillance and outbreak detection. Trends Microbiol 24 (2016), 241–245.
82. WHO, Developing global norms for sharing data and results during public health emergencies. 2015, WHO Available at: http://www.who.int/medicines/ebola-treatment/data-sharing_phe/en.
83. WHO, Policy statement on data sharing by the World Health Organization in the context of public health emergencies. 2016, WHO Available at: http://www.who.int/ihr/procedures/SPG_data_sharing.pdf.
84. GLOPID-R, Glopid-r makes data sharing a top priority. 2017, GLOPID-R Available at: https://www.glopid-r.org/find-out-about-our-work/data-sharing-working-group/.
85. GISAID, Gisaid. 2017, GISAID https://www.gisaid.org/.
86. Shu, Y., McCauley, J., Gisaid: global initiative on sharing all influenza data—from vision to reality. Euro Surveill, 22, 2017.
87. WHO, Denguenet. 2017, WHO20017 Available at: http://www.who.int/csr/disease/dengue/DengueNetFlyer2006.pdf.
88. Allard, M.W., Strain, E., Melka, D., Bunning, K., Musser, S.M., Brown, E.W., et al. Practical value of food pathogen traceability through building a whole-genome sequencing network and database. J Clin Microbiol 54 (2016), 1975–1983.
89. Reusken, C.B., Mögling, R., Smit, P.W., Grunow, R., Ippolito, G., Di Caro, A., et al. Status, quality and specific needs of Ebola virus diagnostic capacity and capability in laboratories of the two European preparedness laboratory networks EMERGE and EVD-LabNet. Eurosurveillance, 2018 In Press.
90. EVAg, European virus archive goes global. 2015, EVAg Available at: https://www.european-virus-archive.com/.
91. EVD-LabNet, European expert laboratory network for emerging viral diseases. 2016, EVD-LabNet Available at: https://www.evd-labnet.eu/.
92. EMERGE, Emerge JA: efficient response to highly dangerous and emerging pathogens at EU level. 2016, EMERGE JA Available at: http://www.emerge.rki.eu.
93. Huzly, D., Hanselmann, I., Schmidt-Chanasit, J., Panning, M., High specificity of a novel zika virus ELISA in European patients after exposure to different flaviviruses. Euro Surveill, 21, 2016.
94. Steinhagen, K., Probst, C., Radzimski, C., Schmidt-Chanasit, J., Emmerich, P., van Esbroeck, M., et al. Serodiagnosis of zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016. Euro Surveill, 21, 2016.
95. Granger, D., Hilgart, H., Misner, L., Christensen, J., Bistodeau, S., Palm, J., et al. Serologic testing for zika virus: comparison of three zika virus IgM-screening enzyme-linked immunosorbent assays and initial laboratory experiences. J Clin Microbiol 55 (2017), 2127–2136.
96. L'Huillier, A.G., Hamid-Allie, A., Kristjanson, E., Papageorgiou, L., Hung, S., Wong, C.F., et al. Evaluation of Euroimmun anti-zika virus IgM and IgG enzyme-linked immunosorbent assays for zika virus serologic testing. J Clin Microbiol 55 (2017), 2462–2471.
97. Grunow, R., Ippolito, G., Jacob, D., Sauer, U., Rohleder, A., Di Caro, A., et al. Benefits of a European project on diagnostics of highly pathogenic agents and assessment of potential “dual use” issues. Front Public Health, 2, 2014, 199.
98. Domingo, C., Escadafal, C., Rumer, L., Mendez, J.A., Garcia, P., Sall, A.A., et al. First international external quality assessment study on molecular and serological methods for yellow fever diagnosis. PLoS One, 7, 2012, e36291.
99. Domingo, C., Niedrig, M., Teichmann, A., Kaiser, M., Rumer, L., Jarman, R.G., et al. 2nd international external quality control assessment for the molecular diagnosis of dengue infections. PLoS Negl Trop Dis, 4, 2010.
100. Donoso Mantke, O., Aberle, S.W., Avsic-Zupanc, T., Labuda, M., Niedrig, M., Quality control assessment for the PCR diagnosis of tick-borne encephalitis virus infections. J Clin Virol 38 (2007), 73–77.
101. Donoso Mantke, O., Lemmer, K., Biel, S.S., Groen, J., Schmitz, H., Durand, J.P., et al. Quality control assessment for the serological diagnosis of dengue virus infections. J Clin Virol 29 (2004), 105–112.
102. Donoso Mantke, O., Schmitz, H., Zeller, H., Heyman, P., Papa, A., Niedrig, M., et al. Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe. Euro Surveill 10 (2005), 102–106.
103. Ellerbrok, H., Jacobsen, S., Patel, P., Rieger, T., Eickmann, M., Becker, S., et al. External quality assessment study for ebolavirus PCR-diagnostic promotes international preparedness during the 2014–2016 ebola outbreak in West Africa. PLoS Negl Trop Dis, 11, 2017, e0005570.
104. Pas, S.D., Patel, P., Reusken, C., Domingo, C., Corman, V.M., Drosten, C., et al. First international external quality assessment of molecular diagnostics for MERS-COV. J Clin Virol 69 (2015), 81–85.
105. Escadafal, C., Avsic-Zupanc, T., Vapalahti, O., Niklasson, B., Teichmann, A., Niedrig, M., et al. Second external quality assurance study for the serological diagnosis of hantaviruses in Europe. PLoS Negl Trop Dis, 6, 2012, e1607.
106. Escadafal, C., Olschlager, S., Avsic-Zupanc, T., Papa, A., Vanhomwegen, J., Wolfel, R., et al. First international external quality assessment of molecular detection of Crimean-Congo hemorrhagic fever virus. PLoS Negl Trop Dis, 6, 2012, e1706.
107. Escadafal, C., Paweska, J.T., Grobbelaar, A., le Roux, C., Bouloy, M., Patel, P., et al. International external quality assessment of molecular detection of Rift Valley fever virus. PLoS Negl Trop Dis, 7, 2013, e2244.
108. Charrel, R., Mogling, R., Pas, S., Papa, A., Baronti, C., Koopmans, M., et al. Variable sensitivity in molecular detection of zika virus in European expert laboratories; external quality assessment, November 2016. J Clin Microbiol 55 (2017), 3219–3226.
109. WHO, Polio outbreak simulation exercise. 2015, WHO Available at: http://www.euro.who.int/__data/assets/pdf_file/0004/290407/Polio-Outbreak-Simulation-Exercise.pdf.
110. Geering, W., Glyn Davies, F., Martin, V., Traing, and testing and revision of contigency plans. Geering, W., Glyn Davies, F., Martin, V.J., (eds.) FAO animal health manual: preparation of Rift Valley fever contigency plans, 2002, FAO, Rome, 61–63.
111. ECDC, ECDC public health training section; catalogue 2017–2018 ECDC continuous professional development programme. 2017, ECDC Available at: https://ecdc.europa.eu/sites/portal/files/documents/ECDC%20Training%20Catalogue%20_2017_2018_outline.pdf.
112. PANDEM, Pandem; pandemic risk and emergency management. 2017, PANDEM Available at: http://www.pandem.eu.com/.
113. COMPARE, Collaborative management platform for detection and analyses of (re-) emerging and foodborne outbreaks in Europe. 2016, COMPARE Available at: http://www.compare-europe.eu/.
114. ERINHA, Erinha; european research infrastructure on highly pathogenic agents. 2017, ERINHA Available at: http://www.erinha.eu/.
115. PREPARE, Platform for european preparedness against (re-)emerging epidemics. 2015 Available at: http://www.prepare-europe.eu/.
116. ZAPI, Zoonoses anticipation and preparedness initiative. 2017, IMI Available at: http://zapi-imi.eu/.
117. Cleton, N.B., Reusken, C.B., Wagenaar, J.F., van der Vaart, E.E., Reimerink, J., van der Eijk, A.A., et al. Syndromic approach to arboviral diagnostics for global travelers as a basis for infectious disease surveillance. PLoS Negl Trop Dis, 9, 2015, e0004073.
118. Waggoner, J.J., Gresh, L., Vargas, M.J., Ballesteros, G., Tellez, Y., Soda, K.J., et al. Viremia and clinical presentation in nicaraguan infected with zika virus, chikungunya virus, and dengue virus. Clin Infect Dis 63 (2016), 1584–1590.
119. Buchy, P., Peeling, R., Laboratory diagnosis and diagnostic tests. WHO, (eds.) Dengue: guidelines for diagnosis, treatment, prevention and control: new edition, 2009, WHO press, Geneva, 91–109.
120. Mardekian, S.K., Roberts, A.L., Diagnostic options and challenges for dengue and chikungunya viruses. Biomed Res Int, 2015, 2015, 834371.
121. Cusi, M.G., Savellini, G.G., Diagnostic tools for toscana virus infection. Expert Rev Anti Infect Ther 9 (2011), 799–805.
122. Waggoner, J.J., Pinsky, B.A., Zika virus: diagnostics for an emerging pandemic threat. J Clin Microbiol 54 (2016), 860–867.
123. van Meer, M.P.A., Mogling, R., Klaasse, J., Chandler, F.D., Pas, S.D., van der Eijk, A.A., et al. Re-evaluation of routine dengue virus serology in travelers in the era of zika virus emergence. J Clin Virol 92 (2017), 25–31.
124. Lindsey, N.P., Fischer, M., Neitzel, D., Schiffman, E., Salas, M.L., Glaser, C.A., et al. Hospital-based enhanced surveillance for West Nile virus neuroinvasive disease. Epidemiol Infect 144 (2016), 3170–3175.
125. Yactayo, S., Staples, J.E., Millot, V., Cibrelus, L., Ramon-Pardo, P., Epidemiology of chikungunya in the Americas. J Infect Dis 214 (2016), S441–S445.
126. Reusken, C.B., Bakker, J., Reimerink, J.H., Zelena, H., Koopmans, M.G., Underdiagnosis of chikungunya virus infections in symptomatic Dutch travelers returning from the Indian Ocean area. J Travel Med 20 (2013), 44–46.
127. Tonteri, E., Kurkela, S., Timonen, S., Manni, T., Vuorinen, T., Kuusi, M., et al. Surveillance of endemic foci of tick-borne encephalitis in Finland 1995–2013: evidence of emergence of new foci. Euro Surveill, 20, 2015.
128. Calzolari, M., Bonilauri, P., Bellini, R., Albieri, A., Defilippo, F., Tamba, M., et al. Usutu virus persistence and West Nile virus inactivity in the Emilia-Romagna region (Italy) in 2011. PLoS One, 8, 2013, e63978.
129. GIDEON, Gideon, the world's premier global infectious diseases database. 2017, GIDEON Available at: https://www.gideononline.com/.
130. Fernandez-Garcia, M.D., Negredo, A., Papa, A., Donoso-Mantke, O., Niedrig, M., Zeller, H., et al. European survey on laboratory preparedness, response and diagnostic capacity for Crimean-Congo haemorrhagic fever, 2012. Euro Surveill, 19, 2014.
131. Sambri, V., Capobianchi, M.R., Cavrini, F., Charrel, R., Donoso-Mantke, O., Escadafal, C., et al. Diagnosis of West Nile virus human infections: overview and proposal of diagnostic protocols considering the results of external quality assessment studies. Viruses 5 (2013), 2329–2348.
132. EVD-LabNet, EVD-LabNet diagnostic directory. 2017, EVD-LabNet Available at: https://evd-labnet.eu/evd-labnet-directory-search.
133. Niedrig, M., Avsic, T., Aberle, S.W., Ferenczi, E., Labuda, M., Rozentale, B., et al. Quality control assessment for the serological diagnosis of tick borne encephalitis virus infections. J Clin Virol 38 (2007), 260–264.
134. Anonymous, Government will distribute 3.5 million zika virus tests. 2016, Government of Brazil Available at: http://www.brazilgovnews.gov.br/news/2016/10/government-will-distribute-3-5-million-zika-virus-tests.
135. Jacobsen, S., Patel, P., Schmidt-Chanasit, J., Leparc-Goffart, I., Teichmann, A., Zeller, H., et al. External quality assessment studies for laboratory performance of molecular and serological diagnosis of chikungunya virus infection. J Clin Virol 76 (2016), 55–65.
136. Niedrig, M., Zeller, H., Schuffenecker, I., Drosten, C., Emmerich, P., Rumer, L., et al. International diagnostic accuracy study for the serological detection of chikungunya virus infection. Clin Microbiol Infect 15 (2009), 880–884.
137. Lemmer, K., Donoso Mantke, O., Bae, H.G., Groen, J., Drosten, C., Niedrig, M., External quality control assessment in PCR diagnostics of dengue virus infections. J Clin Virol 30 (2004), 291–296.
138. The World Bank, People, pathogens and our planet: the economics of one health. 2012, World Bank Available at: https://openknowledge.worldbank.org/bitstream/handle/10986/11892/691450ESW0whit0D0ESW120PPPvol120web.pdf.
139. Braks, M., Medlock, J.M., Hubalek, Z., Hjertqvist, M., Perrin, Y., Lancelot, R., et al. Vector-borne disease intelligence: strategies to deal with disease burden and threats. Front Public Health, 2, 2014, 280.